Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Lymphoma, Follicular 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Leukemia, Lymphocytic, Chronic, B-Cell 11Leukemia 11Lymphoma, Mantle-Cell 10Lymphoma, B-Cell, Marginal Zone 10Lymphoma 10Lymphoma, Large-Cell, Immunoblastic 9Lymphoma, Large B-Cell, Diffuse 9Lymphoma, Non-Hodgkin 8Leukemia, Myeloid, Chronic-Phase 8Leukemia, Myeloid, Acute 8Congenital Abnormalities 8Burkitt Lymphoma 8Rectal Neoplasms 7Hodgkin Disease 7Head and Neck Neoplasms 7Multiple Myeloma 6Melanoma 6Colonic Neoplasms 6Carcinoma, Renal Cell 6Waldenstrom Macroglobulinemia 5Myeloproliferative Disorders 5Lymphoma, T-Cell, Cutaneous 5Leukemia, Myeloid, Accelerated Phase 5Colorectal Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Breast Neoplasms 5Uterine Cervical Neoplasms 4Unspecified Adult Solid Tumor, Protocol Specific 4

Interventions

Doxorubicin 10Zidovudine 9Vincristine 7Bleomycin 7Nivolumab 6Liposomes 5Interferon alpha-2 5Etoposide 5tecogalan 4pembrolizumab 4liposomal doxorubicin 4Valganciclovir 4Specimen Handling 4Semaxinib 4Paclitaxel 4Nelfinavir 4Magnetic Resonance Spectroscopy 4pomalidomide 3Ritonavir 3Filgrastim 3Biopsy 3Bevacizumab 3technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 2sargramostim 2interferon alfa-n1 2Propranolol 2Indinavir 2Docetaxel 2Didanosine 2Daunorubicin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Sarcoma, Kaposi × Polymerase Chain Reaction × Clear all
NCT00686842 2018-06-06

PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma

AIDS Malignancy Consortium

Phase 1/2 Terminated
17 enrolled 7 charts
Sarcoma

AIDS-related Kaposi sarcoma, Sarcoma, Kaposi, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡